{
    "clinical_study": {
        "@rank": "89130", 
        "acronym": "ROSE", 
        "arm_group": [
            {
                "arm_group_label": "ROSE", 
                "arm_group_type": "Other", 
                "description": "In the case of ROSE, sampling frequency will occur similarly, but no additional samples will be taken in the case of provision of a preliminary diagnosis."
            }, 
            {
                "arm_group_label": "NO ROSE", 
                "arm_group_type": "Other", 
                "description": "In the case of no ROSE, sampling frequency will be predetermined at 4 needle aspirations per site"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is comparing the attributable procedural time of Endobronchial\n      Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) when sampling mediastinal and\n      hilar lymph nodes with or without Rapid On-Site Evaluation (ROSE). The primary outcome will\n      be the time elapsed from EBUS bronchoscope insertion to bronchoscope withdrawal. Secondary\n      outcomes will include total number of sampled lymph nodes, average number of needle\n      aspirations per lymph node sampled, overall diagnostic yield, and procedural time of the\n      cytopathologist."
        }, 
        "brief_title": "Procedural Outcomes in Endobronchial Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) With and Without Rapid On-Site Evaluation (ROSE)", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "ENDOBRONCHIAL ULTRASOUND - TRANSBRONCHIAL NEEDLE ASPIRATION", 
            "Benign and Malignant Mediastinal and Hilar Lymph Nodes Known or Suspected Malignancy"
        ], 
        "condition_browse": {
            "mesh_term": "Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject provides informed consent\n\n          2. Subject is >18 years of age\n\n          3. Subject is scheduled to undergo flexible bronchoscopy with EBUS-TBNA of suspected\n             enlarged mediastinal or hilar  lymph nodes as part of their standard medical care\n\n          4. A negative pregnancy test in women of child-bearing potential\n\n          5. Subject is mentally capable of following study directions\n\n        Exclusion Criteria:\n\n          1. Study subject has any disease or condition that interferes with safe completion of\n             initial or follow-up assessments\n\n          2. Concurrent participation in another study involving investigational drugs or\n             investigational medical devices\n\n          3. Inability to read and understand the necessary study documents"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02028052", 
            "org_study_id": "Pro00036432"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "ROSE", 
                    "NO ROSE"
                ], 
                "description": "The procedure will proceed with conventional EBUS-TBNA sampling of the target lesion with 22 gauge Vizishot needles. Each subject will be randomized to either ROSE by cytopathologist or no ROSE.", 
                "intervention_name": "ROSE", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": [
                    "ROSE", 
                    "NO ROSE"
                ], 
                "intervention_name": "22 gauge Vizishot needles", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "enlarged mediastinal nodes", 
            "enlarged hilar lymph nodes"
        ], 
        "lastchanged_date": "January 6, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27710"
                }, 
                "name": "Duke University Medical Center"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Procedural Outcomes in Endobronchial Ultrasound - Transbronchial Needle Aspiration (EBUS-TBNA) With and Without Rapid On-Site Evaluation (ROSE) by Cytopathologist", 
        "overall_official": {
            "affiliation": "Duke University", 
            "last_name": "Momen Wahidi, MD, MBA", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary endpoint is the time elapsed from EBUS bronchoscope insertion to bronchoscope withdrawal.", 
            "measure": "Time lapse", 
            "safety_issue": "No", 
            "time_frame": "during procedure, approximately 45 minutes"
        }, 
        "reference": [
            {
                "PMID": "15249452", 
                "citation": "Yasufuku K, Chiyo M, Sekine Y, Chhajed PN, Shibuya K, Iizasa T, Fujisawa T. Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest. 2004 Jul;126(1):122-8."
            }, 
            {
                "PMID": "1076725", 
                "citation": "Mejia CP. [Surgery and orthodontics in the treatment of unerupted maxillary cuspids]. Rev Fed Odontol Colomb. 1976 Jan-Jun;24(116-117):47-52. Spanish."
            }, 
            {
                "PMID": "22145008", 
                "citation": "Griffin AC, Schwartz LE, Baloch ZW. Utility of on-site evaluation of endobronchial ultrasound-guided transbronchial needle aspiration specimens. Cytojournal. 2011;8:20. doi: 10.4103/1742-6413.90081. Epub 2011 Nov 21."
            }, 
            {
                "PMID": "11668466", 
                "citation": "Layfield LJ, Bentz JS, Gopez EV. Immediate on-site interpretation of fine-needle aspiration smears: a cost and compensation analysis. Cancer. 2001 Oct 25;93(5):319-22."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02028052"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Samples taken during procedure", 
                "measure": "Total number of sampled lymph nodes", 
                "safety_issue": "No", 
                "time_frame": "approximately 45 minutes"
            }, 
            {
                "description": "Determined by tumor", 
                "measure": "Average number of needle aspirations per lymph node sampled", 
                "safety_issue": "No", 
                "time_frame": "approximately 45 minutes"
            }, 
            {
                "measure": "Overall diagnostic yield", 
                "safety_issue": "No", 
                "time_frame": "approximately 45 minutes"
            }, 
            {
                "measure": "Procedural time of the cytopathologist", 
                "safety_issue": "No", 
                "time_frame": "approximately 30 minutes"
            }
        ], 
        "source": "Duke University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}